Browse Title Index
| Issue | Title | |
| Vol 10, Supp. A (2019) | Leczenie azacytydyną chorego na wtórną do mielofirozy ostrą białaczkę szpikową | Abstract PDF (Polish) |
| Agnieszka Pluta | ||
| Vol 10, Supp. A (2019) | Leczenie upustami krwi przeładowania żelazem u pacjenta z zespołem mielodysplastycznym w trakcie skutecznego leczenia azacytydyną | Abstract PDF (Polish) |
| Hanna Ciepłuch | ||
| Vol 2, No 4 (2011) | Letter from the Editor | Details PDF (Polish) |
| Krzysztof Warzocha | ||
| Vol 6, No 2 (2015) | Leukemias of T-cell large granular lymphocytes and natural killers | Abstract PDF (Polish) HTML (Polish) |
| Bożena Katarzyna Budziszewska | ||
| Vol 5, No 4 (2014) | Leukemic transformation of polycythemia vera — 2 case reports and review of literature | Abstract PDF (Polish) HTML (Polish) |
| Olga Dobrzyńska, Tomasz Lonc, Karolina Korolik, Tomasz Wróbel | ||
| Vol 9, No 3 (2018) | Light-chain cardiac amyloidosis from the cardiologists’ point of view | Abstract PDF (Polish) |
| Jacek Grzybowski, Justyna Anna Szczygieł, Monika Gawor, Piotr Michałek, Agnieszka Sioma, Natalia Ojrzyńska, Łukasz Mazurkiewicz, Marta Legatowicz-Koprowska, Ewa Walczak, Maria Franaszczyk, Magdalena Marczak | ||
| Vol 4, No 4 (2013) | LISTY DO REDAKCJI | Abstract PDF (Polish) HTML (Polish) |
| Ewa Brojer | ||
| Vol 10, Supp. B (2019) | Long-term efficacy of azacitidine in a patient with acute myeloid leukemia with myelodysplastic-related changes | Abstract PDF (Polish) |
| Marcin Wójtowicz | ||
| Vol 10, Supp. C (2019) | Long-term response on brentuximab vedotin therapy in patients with Hodgkin lymphoma | Abstract PDF (Polish) |
| Andrzej Pluta, Justyna Gil, Jacek Krzanowski, Sławomir Radwański | ||
| Vol 10, Supp. C (2019) | Long-term response to treatment with brentuximab vedotin in a patient with relapse of Hodgkin lymphoma after auto-HSCT | Abstract PDF (Polish) |
| Edyta Subocz, Janusz Hałka | ||
| Vol 10, Supp. B (2019) | Long-term treatment with azacitidine for a higher risk myelodysplastic syndrome | Abstract PDF (Polish) |
| Weronika Piszczek, Grzegorz Charliński | ||
| Vol 11, Supp. A (2020) | Loss of complete cytogenetic response after nilotinib discontinuation | Abstract PDF (Polish) |
| Tomasz Sacha, Joanna Wącław | ||
| Vol 8, No 3 (2017) | Lymphocytic meningitis after intrathecal liposomal cytarabine in a patient with acute lymphoblastic leukemia | Abstract PDF (Polish) HTML (Polish) |
| Aleksandra Gołos, Joanna Góra-Tybor, Ewa Lech-Marańda, Krzysztof Warzocha | ||
| Vol 2, Supp. B (2011) | Major molecular response achieved after nilotinib therapy in the patient suffering from chronic myeloid leukemia with hematologic toxicity associated with imatinib and dasatinib therapy | Abstract PDF (Polish) |
| Tomasz Sacha | ||
| Vol 4, Supp. B (2013) | Major molecular response achieved on the third-line nilotinib therapy in a patient with chronic myelogenous leukemia in chronic phase with suboptimal response to imatinib and dasatinib | Abstract PDF (Polish) |
| Tomasz Sacha | ||
| Vol 4, No 3 (2013) | Management of tyrosine kinase inhibitors adverse effects in patients with chronic myelogenous leukemia | Abstract PDF (Polish) HTML (Polish) |
| Krzysztof Lewandowski | ||
| Vol 1, No 4 (2010) | Mantle cell lymphoma: update on diagnosis and treatment | Abstract PDF (Polish) |
| Michał Szymczyk, Jan Walewski | ||
| Vol 3, No 2 (2012) | Mechanism of action of hypomethylating agents in myelodysplastic syndromes | Abstract PDF (Polish) |
| Lidia Gil, Krzysztof Mądry, Mieczysław Komarnicki | ||
| Vol 10, No 3 (2019) | Mechanism of activity and defensive strategies of cancer cells against TRAIL-induced apoptosis | Abstract PDF (Polish) |
| Karolina Piechna, Przemysław Juszczyński | ||
| Vol 2, No 2 (2011) | Mechanisms of action of immunomodulatory drugs in plasma cell myeloma | Abstract PDF (Polish) |
| Agnieszka Piechnik, Krzysztof Giannopoulos | ||
| Vol 9, No 1 (2018) | Metabolic and water-electorlyte homeostasis disorders in patients with hematologic malignancies | Abstract PDF (Polish) |
| Bożena Katarzyna Budziszewska | ||
| Vol 13, No 2 (2022) | Midostaurin added to standard therapy in FLT3-positive acute myeloid leukaemia treatment | Abstract PDF |
| Andrzej Szczepaniak, Zuzanna Rzetelska | ||
| Vol 12, Supp. D (2021) | Midostaurin added to standard therapy in FLT3-positive acute myeloid leukemia treatment | Abstract PDF |
| Andrzej Szczepaniak, Zuzanna Rzetelska | ||
| Vol 13, No 1 (2022) | Midostaurin in the treatment of a patient with acute myeloid leukaemia with FLT3-TKD mutation and NPM1 mutation | Abstract PDF |
| Aleksander Salomon-Perzyński, Urszula Walczak, Kinga Kos-Zakrzewska, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska | ||
| Vol 12, Supp. D (2021) | Midostaurin in the treatment of patient with acute myeloid leukemia with FLT3-TKD mutation and NPM1 mutation | Abstract PDF |
| Aleksander Salomon-Perzyński, Urszula Walczak, Kinga Kos-Zakrzewska, Ewa Lech-Marańda, Bożena Katarzyna Budziszewska | ||
| 226 - 250 of 543 Items | << < 5 6 7 8 9 10 11 12 13 14 > >> | |
By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl
